Shareholding disclosure

Vincent MUTEL

Declared position

Threshold

Fell below threshold

Timeline

Published

26.10.2012

Transaction

17.10.2011

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TACAP00017

Beneficial owner

Vincent MUTEL

Declared address

Vincent MUTEL, 1180 ROLLE

Franchissement à la baisse du seuil de 3% de participation suite à cession de titres.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Vincent MUTEL

Addex Therapeutics Ltd26.10.2012TACAP00017

Disclosure summary

Vincent MUTEL disclosed a holding in Addex Therapeutics Ltd that fell below the publication threshold, published by SIX Exchange Regulation on 26.10.2012, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Vincent MUTEL disclosed a holding in Addex Therapeutics Ltd, published on 26.10.2012.

Publication date26.10.2012

Transaction date17.10.2011

Issuing companyAddex Therapeutics Ltd

Beneficial ownerVincent MUTEL

Declared addressVincent MUTEL, 1180 ROLLE

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTACAP00017

Conditions

Franchissement à la baisse du seuil de 3% de participation suite à cession de titres.

Source: SIX Exchange Regulation · Publication date: 26.10.2012

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open